Royal Philips (PHG) said Tuesday it received US Food and Drug Administration 510(k) clearance for an artificial intelligence software package designed for its flagship ultrasound systems.

The newly cleared Elevate Plus platform adds automated workflow features and decision support tools to the EPIQ Elite and Affiniti ultrasound systems, the company said.

The system helps automate routine abdominal measurements while providing rapid decision support for classifying breast or thyroid lesions, Royal Philips said.

The software upgrade also introduces advanced visual filters to improve tissue detail clarity and blood flow tracking for medical professionals, it said.

Shares of the company were down 1.6% in Tuesday trading.